United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2020_register
executive
2020-05-21
article
Advisory Committee; Arthritis Advisory Committee; Renewal
Notices
D09002ee1bdb5762d
D09002ee1bdb5768d
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing the renewal of the Arthritis Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Arthritis Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until April 5, 2022.
85 FR 30966
https://www.govinfo.gov/app/details/FR-2020-05-21/2020-10996
2020-10996
fr21my20-46
4164-01-P
Docket No. FDA-2018-N-1242
https://www.govinfo.gov/app/details/FR-2020-05-21/2020-10996
https://www.govinfo.gov/content/pkg/FR-2020-05-21/html/2020-10996.htm
https://www.govinfo.gov/content/pkg/FR-2020-05-21/pdf/2020-10996.pdf
1 p.
30966
30966
85 FR 30966
Advisory Committee; Arthritis Advisory Committee; Renewal; Federal Register Vol. 85, Issue
NOTICE
2020-10996
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2018-N-1242
4164-01-P
2020-10996
Notice; renewal of advisory committee.
The Food and Drug Administration (FDA) is announcing the renewal of the Arthritis Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Arthritis Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until April 5, 2022.
Authority for the Arthritis Advisory Committee would have expired on April 5, 2020, unless the Commissioner had formally determined that renewal is in the public interest.
Yinghua Wang, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, AAC@fda.hhs.gov.
AAC@fda.hhs.gov
https://www.fda.gov/advisory-committees
https://www.fda.gov/advisory-committees/human-drug-advisory-committees/arthritis-advisory-committee
Federal Register
Vol. 85, no. 99
Office of the Federal Register, National Archives and Records Administration
2020-05-21
continuing
daily
deposited
born digital
218 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2020-05-21
P0b002ee1a6fc5522
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr21my20
https://www.govinfo.gov/app/details/FR-2020-05-21
https://www.govinfo.gov/content/pkg/FR-2020-05-21/pdf/FR-2020-05-21.pdf
https://www.govinfo.gov/content/pkg/FR-2020-05-21/xml/FR-2020-05-21.xml
fdlp
30825
31033
DGPO
2020-05-21
2023-04-27
FR-2020-05-21
machine generated
eng
FR
FR-2020-05-21
85
99